Physician profile
Ronald D Jacobs
NPI 1558358853
$1,591.20
in general payments reported to CMS, 2019-2025
21 companies · $36.13 in 2025
The $36.13 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $288 · 2021: $569 · 2022: $190 · 2023: $186 · 2024: $34.85 · 2025: $36.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $470.26 | 2019-2024 | |
| Aspira Women'S Health INC | $172.16 | 2019-2024 | Ova1 |
| Coopersurgical, INC. | $155.89 | 2019-2023 | Endosee, Summit Doppler |
| Pfizer INC. | $136.64 | 2019-2022 | |
| Avion Pharmaceuticals | $121.29 | 2020-2023 | Balcoltra |
| Exeltis, USA INC. | $97.56 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $57.34 | 2020 | |
| Allergan, INC. | $52.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.09 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $36.62 | 2022-2023 | |
| Cumberland Pharmaceuticals, INC. | $35.56 | 2019-2025 | Kristalose |
| Evofem Biosciences, INC. | $29.90 | 2021-2022 | |
| Agile Therapeutics, INC. | $29.18 | 2021 | |
| Organon LLC | $29.10 | 2022-2025 | Nexplanon |
| Duchesnay USA Incorporated | $23.57 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $20.00 | 2019 | |
| Amgen INC. | $19.91 | 2021 | |
| Amag Pharmaceuticals, INC. | $19.00 | 2019 | |
| Astellas Pharma US INC | $14.88 | 2021 | |
| Daiichi Sankyo INC. | $14.69 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.